Available For Sale Securities Debt Securities Current

Veradermics Available For Sale Securities Debt Securities Current increased by 85.2% to $222.39M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ4 2024

Last reportedQ1 2026

How to read this metric

An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate the use of cash for operations or acquisitions.

Detailed definition

This represents the fair value of debt securities held by the company that are classified as available-for-sale and are...

Peer comparison

Commonly reported by large-cap technology firms as 'Short-term investments' or 'Available-for-sale securities'.

Metric ID: current_assets_available_for_sale_securities_debt_securi_87ec82

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$120.10M	$222.39M
QoQ Change	—	+85.2%

Range$120.10M – $222.39M

Frequently Asked Questions

What is Veradermics 's available for sale securities debt securities current?: Veradermics (MANE) reported available for sale securities debt securities current of $222.39M in Q1 2026.
What does available for sale securities debt securities current mean?: The value of short-term debt investments that the company intends to sell within a year.